Plus Therapeutics, (NASDAQ: PSTV) announced that it has officially changed its name from Cytori Therapeutics, Inc. to Plus Therapeutics, Inc. The company’s ticker symbol for its common stock on the Nasdaq Capital Market changed from ‘CYTX’ to ‘PSTV’ and the ticker symbol for its Series S Warrants changed from ‘CYTXZ’ to ‘PSTVZ’. In the news release, Plus Therapeutics detailed its plans to make a 1-for-50 reverse stock split become effective on August 5, 2019, transforming every 50 shares of the company’s common stock into one issued and outstanding share without any change in the par value of the shares. Following the reverse stock split, the company anticipated that the number of outstanding shares of its common stock would be proportionally reduced from approximately 22.2 million to approximately 0.4 million.
To view the full press release, visit: http://nnw.fm/rvS5w
About Plus Therapeutics, Inc.
Plus Therapeutics is a clinical-stage pharmaceutical company focused on making a positive impact on patients’ lives and adding value to the healthcare system. Plus Therapeutics is a Nasdaq-listed company with headquarters located in Austin, TX. Plus also has a manufacturing facility in San Antonio, TX and a satellite office in San Diego, CA. The lead product candidate in the company’s pipeline, DocePLUS, is being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, and other professionals. This diverse and experienced team is using the company’s proprietary and versatile nanotechnology platform in an effort to reformulate and improve conventional, workhorse chemotherapeutics to provide meaningful benefits to patients and healthcare providers. The platform also serves as the foundation and affords the company the opportunity in the future to develop additional drugs for oncology and other therapeutic areas. For more information, visit the company’s website at www.PlusTherapeutics.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text "STOCKS" to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com